Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Rang în acțiuni #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Preț acțiune
$59.98
Ultima sincronizare: 2024-12-13
Capitalizare de piață
$1.22B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Longboard Pharmaceuticals, Inc. (LBPH)

Categorie

Raport P/B pentru Longboard Pharmaceuticals, Inc. (LBPH)
Raport P/B la data de August 2026 TTM: 33.31
Conform celor mai recente rapoarte financiare și prețului acțiunilor Longboard Pharmaceuticals, Inc., raportul P/B actual (TTM) este 33.31. La sfârșitul anului 2022, compania avea un P/B de 0.91.
Istoricul raportului P/B pentru Longboard Pharmaceuticals, Inc. din 2020 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
2026 (TTM) 33.31 894.31%
2023 3.35 268.15%
2022 0.91 12.83%
2021 0.81 -85.45%
2020 5.54 0.00%
Raport P/B pentru companii similare sau competitoare
Companie Raport P/B Diferență raport P/B Țara
6.3419 -80.96%
US
6.2413 -81.26%
NL
2.5054 -92.48%
AU
3.7087 -88.87%
US
- -
CH